Búsqueda | BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas

1.

Exatecan in pretreated adult patients with advanced soft tissue sarcoma: results of a phase II--study of the EORTC Soft Tissue and Bone Sarcoma Group.

Reichardt, P; Nielsen, O S; Bauer, S; Hartmann, J T; Schöffski, P; Christensen, T B; Pink, D; Daugaard, S; Marreaud, S; Van Glabbeke, M; Blay, J Y.

Eur J Cancer ; 43(6): 1017-22, 2007 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-17336054

2.

Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer.

Piccart, M J; Klijn, J; Paridaens, R; Nooij, M; Mauriac, L; Coleman, R; Bontenbal, M; Awada, A; Selleslags, J; Van Vreckem, A; Van Glabbeke, M.

J Clin Oncol ; 15(9): 3149-55, 1997 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-9294478

3.

Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer.

Chevallier, B; Fumoleau, P; Kerbrat, P; Dieras, V; Roche, H; Krakowski, I; Azli, N; Bayssas, M; Lentz, M A; Van Glabbeke, M.

J Clin Oncol ; 13(2): 314-22, 1995 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-7844592

4.

Randomized phase II study of docetaxel versus doxorubicin in first- and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: a study of the european organization for research and treatment of cancer soft tissue and bone sarcoma group.

Verweij, J; Lee, S M; Ruka, W; Buesa, J; Coleman, R; van Hoessel, R; Seynaeve, C; di Paola, E D; van Glabbeke, M; Tonelli, D; Judson, I R.

J Clin Oncol ; 18(10): 2081-6, 2000 May.

Artículo en Inglés | MEDLINE | ID: mdl-10811673

5.

Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix.

Lhommé, C; Fumoleau, P; Fargeot, P; Krakowski, Y; Dieras, V; Chauvergne, J; Vennin, P; Rebattu, P; Roche, H; Misset, J L; Lentz, M A; Van Glabbeke, M; Matthieu-Boué, A; Mignard, D; Chevallier, B.

J Clin Oncol ; 17(10): 3136-42, 1999 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-10506610

6.

Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group.

Conroy, T; Etienne, P L; Adenis, A; Wagener, D J; Paillot, B; François, E; Bedenne, L; Jacob, J H; Seitz, J F; Bleiberg, H; Van Pottelsberghe, C; Van Glabbeke, M; Delgado, F M; Merle, S; Wils, J.

J Clin Oncol ; 14(1): 164-70, 1996 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-8558192

7.

Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative Group.

Sahmoud, T; Postmus, P E; van Pottelsberghe, C; Mattson, K; Tammilehto, L; Splinter, T A; Planting, A S; Sutedja, T; van Pawel, J; van Zandwijk, N; Baas, P; Roozendaal, K J; Schrijver, M; Kirkpatrick, A; Van Glabbeke, M; Ardizzoni, A; Giaccone, G.

Eur J Cancer ; 33(13): 2211-5, 1997 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-9470808

8.

Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group.

Schlemmer, M; Reichardt, P; Verweij, J; Hartmann, J T; Judson, I; Thyss, A; Hogendoorn, P C W; Marreaud, S; Van Glabbeke, M; Blay, J Y.

Eur J Cancer ; 44(16): 2433-6, 2008 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-18771914

9.

Current status of Taxotere (docetaxel) as a new treatment in breast cancer.

Fumoleau, P; Chevallier, B; Kerbrat, P; Dieras, V; Azli, N; Bayssas, M; Van Glabbeke, M.

Breast Cancer Res Treat ; 33(1): 39-46, 1995.

Artículo en Inglés | MEDLINE | ID: mdl-7749131

10.

Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group.

van Hoesel, Q G; Verweij, J; Catimel, G; Clavel, M; Kerbrat, P; van Oosterom, A T; Kerger, J; Tursz, T; van Glabbeke, M; van Pottelsberghe, C.

Ann Oncol ; 5(6): 539-42, 1994 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-7918126

11.

Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group.

van Meerbeeck, J; Debruyne, C; van Zandwijk, N; Postmus, P E; Pennucci, M C; van Breukelen, F; Galdermans, D; Groen, H; Pinson, P; van Glabbeke, M; van Marck, E; Giaccone, G.

Br J Cancer ; 74(6): 961-3, 1996 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-8826866

12.

An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Degardin, M; Oliveira, J; Geoffrois, L; Rolland, F; Armand, J P; Bastit, P; Chauvergne, J; Fargeot, P; van Glabbeke, M; Lentz, M A; Tresca, P; Boudillet, J; Fumoleau, P; Cappelaere, P.

Ann Oncol ; 9(10): 1103-7, 1998 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-9834823

BVS Medicinas Tradicionales, Complementarias, e Integrativas en las Américas - MTCI

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: